logo

Integrated Case Study Analysis

   

Added on  2020-10-22

29 Pages9436 Words182 Views
Integrated Case StudyAnalysis

EXECUTIVE SUMMARYThe present report is based on acquisition between two leading pharmacy companies in whichone of them take an initiative talk for the same. It include Pfizer which is pharmaceuticalcompany of United States following a strategy to acquire other brands to achieve profits andmarket share effectively in one stroke. However, the another company which is going to beacquired named as AstraZeneca which is leading company of pharmacy in United Kingdomhaving better goodwill and profit share in UK market. In addition to this, the problem statementis about post acquisition issues which AstraZeneca faced problems related to operations asoverall operational activities and procedures get disrupted. Another issue is about large numberof job losses which is not favourable but Pfizer can gain profit by reducing cost of productionand save money on taxes. The aims of present research include identifying the impact of post-acquisition on business operations and employee of AstraZeneca and determining purpose ofPfizer to buy AstraZeneca Company. The given investigation will focus on problems faced byacquired company and benefits of acquirer organisation to evaluate correct solution to facilitatethis acquisition.

Table of ContentsEXECUTIVE SUMMARY.............................................................................................................2CHAPTER 1: Introduction .............................................................................................................51.1 Background of the the study.............................................................................................51.2 Purpose of the study.........................................................................................................51.3 Statement of the problem..................................................................................................51.4 Research questions...........................................................................................................61.5 Research objectives..........................................................................................................61.6 Structure of the report.......................................................................................................6CHAPTER 2: Case brief..................................................................................................................62.1 Background of the company.............................................................................................62.2 Strengths of the company.................................................................................................72.3 Weaknesses of the company.............................................................................................72.4 Challenges of the company..............................................................................................82.5 Competitors of the company............................................................................................8CHAPTER 3: Problem statement & tools and models to be used...................................................93.1 Problem statement............................................................................................................93.1.1 Impact of post acquisition on business operations and employee of AstraZeneca ......9HR issues................................................................................................................................9Operational issues.................................................................................................................103.1.2 Purpose of Pfizer to buy AstraZeneca company.........................................................113.2 Sources to be used..........................................................................................................133.2.1 Research Strategy........................................................................................................133.2.2 Research approach.......................................................................................................133.2.3 Data collection method ...............................................................................................133.3 Tools and models to be used..........................................................................................143.3.1 Swot analysis...............................................................................................................143.3.2 Transformational leadership........................................................................................163.3.3 Ansoff matrix...............................................................................................................16

3.3.4 Maslow theory of motivation......................................................................................163.3.5 Kotters step model of change management.................................................................17CHAPTER 4: Analysis and Findings............................................................................................174.1 Swot of Pfizer and AstraZeneca ....................................................................................174.2 Transfomational leadership............................................................................................174.3 Ansoff matrix..................................................................................................................174.4 Current position faced by U.K. pharma brand AstraZeneca and U.S. Brand Pfizer......184.5 Change management including models to overcome issues..........................................20Action plan...........................................................................................................................204.6 The differential efficiency model...................................................................................22CHAPTER 5: Conclusion..............................................................................................................235.1 Solutions to the problem.................................................................................................235.2 Conclusion......................................................................................................................235.3 Recommendation............................................................................................................235.4 Scope for further research..............................................................................................245.5 Limitations of the research.............................................................................................24REFERENCES..............................................................................................................................25APPENDICES...............................................................................................................................28

CHAPTER 1: Introduction 1.1 Background of the the studyThe present report will focus on analysis of two pharmacy companies including Pfizerand AstraZeneca in which one of them initiated talks regarding possible acquisition betweenthem. Acquisition can be described as a situation in which a company purchase another businessconcern in order to take control for the same. It consist the condition when a company purchasemore than 50% or overall shares to gain ownership of other target firm to enhance theirproductivity and size (Jack, 2014). In addition to this, it is necessary to analyse overallchallenges and benefits of these organisations after acquisition including the fact that Pfizer cangain favourable benefits by acquire other company in order to improve efficiencies through costcutting which facilitate boost up profitability of business. However, it is essential to determineoverall consequences, challenges and benefits from the forthcoming acquisition in order toimplement the same in practical manner which is suitable for both the organisations. 1.2 Purpose of the studyThe purpose of the study is to analyse overall aspects like profitability, operationaldisturbance, employee disturbance, finance and other factors. It is necessary to determineimpacts of acquisition on staff members and operational activities of both companies whichprovide support to make an appropriate decision for completing the same. However, the purposeof this study is to evaluate overall circumstances of business operations, taxation rates, employeeproblems and other issues faced by organisations (Kolditz and et. al., 2016). In addition to this, itwill render help to conduct meetings and make correct decision by establishing accurate contractamong both companies i.e. Pfizer and AstraZeneca accordingly. 1.3 Statement of the problemThe statement of problem is “the proposed price of deal for acquisition is undervalued itspipeline and integration of two companies would disrupt operations and workers of AstraZenecaface significant job losses. Herein, this statement indicates that if both the organisation mergetogether than they disrupt the operation of workers in competitive market of pharmaceutical(Nicholas and Steyn, 2017). As workers of AstraZeneca are facing many issues and problems asthey have loosed their job. Moreover, if the merger would disrupt operation and activities of

worker then their will high number of turnover of employees and staff member which lead tocreate negative image in competitive marketplace. 1.4 Research questionsHow to identify the impact of post acquisition on business operations and employee ofAstraZeneca?What is the purpose of Pfizer to buy AstraZeneca company? 1.5 Research objectivesTo identify the impact of post acquisition on business operations and employee ofAstraZeneca.To explore the purpose of Pfizer to buy AstraZeneca company.1.6 Structure of the reportThe present will include the problem faced by Pfizer to buy AstraZeneca company andimpacts of post acquisition on the operations and employees of the take over firm. It include toanalyse the overall aspects related to both organisations and determine suitability in order tomake correct decision for doing the same practically (Soria and et. al., 2015). However, it willinvolve brief of given case in order to analyse strength and weaknesses of selected organisationalong with determining challenges faced by firm as well as their competitors. Moreover, it will consist literature reviews about research questions including impact ofpost acquisition on operations and purpose of the same. In addition to this, the analysis collecteddata is required to be done and provide discussion about findings of overall investigation inproper way (Uhl and Gollenia, 2016). Meanwhile, the analysis of obtained solutions to specificproblems & issues and appropriate recommendations are given below.CHAPTER 2: Case brief2.1 Background of the companyThe given investigation include two organisations such as Pfizer and AstraZeneca whichare deals in pharmacy and provide medicines for different types of health problems. Initially,Pfizer is a US based company is known as largest pharmaceutical organisation at global levelhaving revenue of $52 billion along with $192 billion market capitalisation at the end of the year(Lientz and Rea, 2016). It was founded by Charles Pfixer & Charles F. Erhart in the year around1849 in New York and it pioneered the mas production of penicillin in 1940s. This company has

End of preview

Want to access all the pages? Upload your documents or become a member.

Related Documents
The Shades – Hair and Beauty Salon Business Plan
|56
|14153
|1574

TABLE OF CONTENTS Chapter 1: Introduction 1 1.1 Introduction 1 1.2 Research problem 4 Chapter 2: Structure of the case study
|46
|16526
|338

Impact of Mergers and Acquisition | Chinese E-Commerce
|33
|7974
|191

(PDF) Management of health, safety and environment
|23
|5965
|48

Evolution of Mergers and Acquisitions
|41
|11661
|78

Impact of Mergers & Acquisitions on Shareholder Wealth in EU Banking Sector
|33
|9703
|167